Evidence map›Paper›PMID 37373853›Full record

ArticleJournal of clinical medicine2023

Diagnostic Usefulness of Spiroergometry and Risk Factors of Long COVID in Patients with Normal Left Ventricular Ejection Fraction.

Katarzyna Gryglewska-Wawrzak, Agata Sakowicz, Maciej Banach, Ibadete Bytyçi, Agata Bielecka-Dabrowa

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04828629 (Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04828629 unknown statusnot on this map

Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity

TypeobservationalSponsorPolish Mother Memorial Hospital Research InstituteRan2020 to 2025Enrolled100ConditionsCovid19, Heart FailureArmsDiagnostic tests
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Katarzyna Gryglewska-WawrzakHeart Failure Unit, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland.ORCID 0000-0001-7902-3042
Agata SakowiczDepartment of Medical Biotechnology, Medical University of Lodz, 90-752 Lodz, Poland.ORCID 0000-0002-5083-2046
Maciej BanachHeart Failure Unit, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland.ORCID 0000-0001-6690-6874
Ibadete BytyçiDepartment of Public Health and Clinical Medicine, Umeå University, 901 87 Umeå, Sweden.ORCID 0000-0002-8996-4257
Agata Bielecka-DabrowaHeart Failure Unit, Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), 93-338 Lodz, Poland.ORCID 0000-0001-6666-3999
Medical University of Lodz · PLPolish Mother’s Memorial Hospital Research Institute · PLUniversity Clinical Center of Kosovo · XK

Funding

Polish Mother's Memorial Hospital Research Institute PMMHRI-BCO.75/2020
6 · The paper itself

Abstract

The emergence of the Coronavirus Disease 2019 (COVID-19) pandemic has brought forth various clinical manifestations and long-term complications, including a condition known as long COVID. Long COVID refers to a persistent set of symptoms that continue beyond the acute phase of the disease. This study investigated the risk factors and the utility of spiroergometry parameters for diagnosing patients with long COVID symptoms. The 146 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with normal left ventricular ejection fraction and without respiratory diseases were included and divided into two groups: the group demonstrating long COVID symptoms [n = 44] and the group without long COVID symptoms [n = 102]. The clinical examinations, laboratory test results, echocardiography, non-invasive body mass analysis, and spiroergometry were evaluated. ClinicalTrials.gov Identifier: NCT04828629. Patients with long COVID symptoms had significantly higher age [58 (vs.) 44 years;

Indexed as

body mass compartmentsCOVID-19exercise intolerancelong COVID syndrome

Identifiers

PMID37373853
PMCPMC10299442
OpenAlexW4381660961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.